We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Waters' (WAT) Q1 Earnings Beat, Revenues Miss Estimates
Read MoreHide Full Article
Waters Corporation (WAT - Free Report) reported first-quarter 2018 non-GAAP earnings of $1.59 per share, which surpassed the Zacks Consensus Estimate by 4 cents. The figure increased 8.9% on a year-over-year basis but declined 36.6% sequentially.
Net sales increased 6.6% year over year but decreased 22.7% sequentially to $531 million. The figure missed the Zacks Consensus Estimate of $533 million.
The year-over-year growth was attributed to improved end-market results, especially in the pharmaceutical market. Moreover, robust performance of Waters and TA product line were also positive.
Top Line in Detail
Waters’ net sales figure can be categorized into four divisions:
By Operating Segment: The company operates in two organized segments – Waters and TA.
Waters segment (88.7% of net sales) witness $471.14 million of sales, up 6.2% from the year-ago quarter. Sales in TA segment came in $59.5 million and accounted for 11.2% of the net sales. The figure was up 9.1% year over year.
By Products & Services: This division is comprises three segments — Instruments, Services and Chemistry.
Instruments sales (45.2% of sales) came in $240.4 million, which was up 2% on a year-over-year basis.
Service sales (36.1% of the sales) were $191.5 million. The figure increased 10% year over year.
Chemistry sales (18.5% of the sales) came in $98.7 million, which was up 12% for the year-ago quarter.
Moreover, service and chemistry sections together generated recurring revenues of $290.2 million, which surged 10.9% year over year.
By Markets: The company serves three end markets — Pharmaceutical, Industrial and Governmental & Academic.
Pharmaceutical market (57.4% of net sales) generated sales of $305.3 million, up 9% on a year-over-year basis.
Industrial market (30.5% of sales) sales came in $162.3 million, which increased 1% from the year-ago quarter.
Governmental & Academic (11.9% of sales) generated $63.01 million of sales. The figure was up 11% year over year.
By Geography: This division includes regions like Asia, Americas and Europe.
Asia (37.7% of net sales) generated $200.3 million of sales for the company. The figure was up 3% on a year-over-year basis.
Americas (34.2% of sales) generated $181.7 million of sales, which was up 4% year over year.
Europe (28% of sales) generated $148.7 million of sales, which increased 16% from prior year quarter.
Waters Corporation Price, Consensus and EPS Surprise
Non-GAAP selling and administrative expenses were $128.8 million, reflecting an increase of 6.18% year over year but decreased 13.4% from the previous quarter.
Research and development outlay for the quarter was $34.5 million, which was up 12.4% year over year but down 1.7% sequentially.
Adjusted operating margin was 27.5%, expanded 40 basis points (bps) but contracted 600 bps sequentially.
Balance Sheet & Cash Flow
As of Mar 31, 2018, cash, cash equivalents and investments came in $2.5 billion, which were lower than $3.4 billion as of Dec 31, 2017. Adjusted free cash flow came in $160 million.
Also, total liabilities were $2.4 billion that came down from $3.1 billion at the end of previous quarter.
Waters also announced a new share repurchase program. The new plans provisions an additional $526 million spending, which takes the totals the purchase authorization to $3.526 billion for a period of three years.
Guidance
For 2018, Waters expects sales growth between 4% and 6% on a constant currency basis. With the currency translation, sales growth is expected in the range of 2-3%.
The company also revised its guidance for non-GAAP earnings in 2018 which are now anticipated to lie within the range of $8.10-$8.30 per share.
Long-term earnings growth rate for Paycom Software, Western Digital and Micron Technology is pegged at 24.75%, 19% and 10%, respectively.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
Image: Bigstock
Waters' (WAT) Q1 Earnings Beat, Revenues Miss Estimates
Waters Corporation (WAT - Free Report) reported first-quarter 2018 non-GAAP earnings of $1.59 per share, which surpassed the Zacks Consensus Estimate by 4 cents. The figure increased 8.9% on a year-over-year basis but declined 36.6% sequentially.
Net sales increased 6.6% year over year but decreased 22.7% sequentially to $531 million. The figure missed the Zacks Consensus Estimate of $533 million.
The year-over-year growth was attributed to improved end-market results, especially in the pharmaceutical market. Moreover, robust performance of Waters and TA product line were also positive.
Top Line in Detail
Waters’ net sales figure can be categorized into four divisions:
By Operating Segment: The company operates in two organized segments – Waters and TA.
Waters segment (88.7% of net sales) witness $471.14 million of sales, up 6.2% from the year-ago quarter. Sales in TA segment came in $59.5 million and accounted for 11.2% of the net sales. The figure was up 9.1% year over year.
By Products & Services: This division is comprises three segments — Instruments, Services and Chemistry.
Instruments sales (45.2% of sales) came in $240.4 million, which was up 2% on a year-over-year basis.
Service sales (36.1% of the sales) were $191.5 million. The figure increased 10% year over year.
Chemistry sales (18.5% of the sales) came in $98.7 million, which was up 12% for the year-ago quarter.
Moreover, service and chemistry sections together generated recurring revenues of $290.2 million, which surged 10.9% year over year.
By Markets: The company serves three end markets — Pharmaceutical, Industrial and Governmental & Academic.
Pharmaceutical market (57.4% of net sales) generated sales of $305.3 million, up 9% on a year-over-year basis.
Industrial market (30.5% of sales) sales came in $162.3 million, which increased 1% from the year-ago quarter.
Governmental & Academic (11.9% of sales) generated $63.01 million of sales. The figure was up 11% year over year.
By Geography: This division includes regions like Asia, Americas and Europe.
Asia (37.7% of net sales) generated $200.3 million of sales for the company. The figure was up 3% on a year-over-year basis.
Americas (34.2% of sales) generated $181.7 million of sales, which was up 4% year over year.
Europe (28% of sales) generated $148.7 million of sales, which increased 16% from prior year quarter.
Waters Corporation Price, Consensus and EPS Surprise
Waters Corporation Price, Consensus and EPS Surprise | Waters Corporation Quote
Operating Details
Non-GAAP selling and administrative expenses were $128.8 million, reflecting an increase of 6.18% year over year but decreased 13.4% from the previous quarter.
Research and development outlay for the quarter was $34.5 million, which was up 12.4% year over year but down 1.7% sequentially.
Adjusted operating margin was 27.5%, expanded 40 basis points (bps) but contracted 600 bps sequentially.
Balance Sheet & Cash Flow
As of Mar 31, 2018, cash, cash equivalents and investments came in $2.5 billion, which were lower than $3.4 billion as of Dec 31, 2017. Adjusted free cash flow came in $160 million.
Also, total liabilities were $2.4 billion that came down from $3.1 billion at the end of previous quarter.
Waters also announced a new share repurchase program. The new plans provisions an additional $526 million spending, which takes the totals the purchase authorization to $3.526 billion for a period of three years.
Guidance
For 2018, Waters expects sales growth between 4% and 6% on a constant currency basis. With the currency translation, sales growth is expected in the range of 2-3%.
The company also revised its guidance for non-GAAP earnings in 2018 which are now anticipated to lie within the range of $8.10-$8.30 per share.
Zacks Rank & Other Stocks to Consider
Waters carries a Zacks Rank #2 (Buy).
A few other top-ranked stocks in the broader technology sector are Paycom Software (PAYC - Free Report) , Western Digital (WDC - Free Report) and Micron Technology (MU - Free Report) . All the three stocks sport Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Long-term earnings growth rate for Paycom Software, Western Digital and Micron Technology is pegged at 24.75%, 19% and 10%, respectively.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
See This Ticker Free >>